12. Congenital myasthenic syndrome
5 clinical trials, 7 drugs (DrugBank: 3 drugs), 5 drug target genes, 12 drug target pathways
Searched query = "Congenital myasthenic syndrome", "End-plate acetylcholine receptor deficiency", "Sodium channel myasthenia", "End-plate acetylcholine esterase deficiency", "Dok-7 myasthenia"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT01203592 (ClinicalTrials.gov) | September 2010 | 15/9/2010 | Efficacy of Albuterol in the Treatment of Congenital Myasthenic Syndromes | Efficacy of Albuterol in the Treatment of Congenital Myasthenic Syndromes | Congenital Myasthenic Syndrome | Drug: Albuterol | Mayo Clinic | NULL | Completed | 2 Years | N/A | Both | 21 | Phase 1 | United States |